2018 Impact factor 2.612

EPJ Plus – Focus on Hadron Therapy in Europe

Oncological hadron therapy was first proposed 65 years ago by Robert R. Wilson, and it took more than 40 years to build the first dedicated facility, in Loma Linda in the nineties. The growth of new facilities since then has been exponential, and thousands of patients are now treated every year. Close collaboration between research institutes, clinical centers and industry is the basis and the future of this field. This EPJ Plus focus issue spotlights the status of hadron therapy in Europe, where different centers are already in operation, some are just now ready to start patient treatments, and new ones are being planned. more

Paolo Biscari
The authors wish to thank the anonymous reviewers for their helpful comments and suggestions. They are also grateful to EPJP for their corrections pertaining to the English language.

E. Tala-Tebue, University of Dschang, Bandjoun, Cameroon

ISSN: 2190-5444 (Electronic Edition)

© Società Italiana di Fisica and